Indeed, the overexpression of NER-related gene ERCC1 (excision repair 1, endonuclease non-catalytic subunit) is associated with cisplatin resistance and negatively correlates with patient outcomes upon cisplatin treatment in non-small cell lung cancer (NSCLC) patients [73]. Here, ERCC1 is linked to non-small cell lung carcinoma.